Solid Attenuation Components Attention Deep Learning Model to Predict Micropapillary and Solid Patterns in Lung Adenocarcinomas on Computed Tomography Li-Wei ChenShun-Mao YangChung-Ming Chen Thoracic Oncology 05 July 2022 Pages: 7473 - 7482
ASO Visual Abstract: Solid Attenuation Components Attention Deep Learning Model to Predict Micropapillary and Solid Patterns in Lung Adenocarcinomas on Computed Tomography Li-Wei ChenShun-Mao YangChung-Ming Chen ASO Visual Abstract 13 August 2022 Pages: 7483 - 7484
Disparate Access to Surgery for Operable Carcinoma of the Lung in North Carolina Aundrea L. OliverCaitlin Takahashi-PipkinWilliam D. Irish Thoracic Oncology 09 July 2022 Pages: 7485 - 7493
ASO Author Reflections: Identifying and Understanding Disparities in Access to Surgery: Operable Lung Cancer in North Carolina Ashley E. BurchJan H. WongWilliam D. Irish ASO Author Reflections 12 July 2022 Pages: 7494 - 7495
ASO Visual Abstract: Disparate Access to Surgery for Operable Carcinoma of the Lung in North Carolina Aundrea L. OliverCaitlin Takahashi-PipkinWilliam D. Irish ASO Visual Abstract 21 July 2022 Pages: 7496 - 7497
Robotic-Assisted Esophagectomy Leads to Significant Reduction in Postoperative Acute Pain: A Retrospective Clinical Trial Jens P. HoelzenKarl J. SanderAndreas Pascher Thoracic Oncology Open access 19 July 2022 Pages: 7498 - 7509
ASO Visual Abstract: Robotic-Assisted Esophagectomy Leads to Significant Reduction in Postoperative Acute Pain—A Retrospective Clinical Trial Jens P. HoelzenKarl J. SanderAndreas Pascher ASO Visual Abstract 30 July 2022 Pages: 7510 - 7511
Impact of Lymph Node Dissection on Survival and Tumor Recurrence for Patients with Resected cT1-2N0 Small Cell Lung Cancer Xinghua ChengWanqin ZengShun Lu Thoracic Oncology 29 July 2022 Pages: 7512 - 7525
ASO Visual Abstract: Impact of Lymph Node Dissection on Survival and Tumor Recurrence in Patients with Resected cT1-2N0 Small-Cell Lung Cancer Xinghua ChengWanqin ZengShun Lu ASO Visual Abstract 13 August 2022 Pages: 7526 - 7526
Thoracoscopic Anatomical Enucleation of GGO Min ZhangMing-jian Ge Thoracic Oncology 05 August 2022 Pages: 7527 - 7527
Impact of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis: A Systematic Review and Meta-analysis Mariana MartinsHugo Santos-SousaBernardo Sousa-Pinto Peritoneal Surface Malignancy 05 August 2022 Pages: 7528 - 7537
ASO Author Reflections: Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis: A Systematic Review and Meta-Analysis Mariana MartinsHugo Santos-SousaBernardo Sousa-Pinto ASO Author Reflections 30 July 2022 Pages: 7538 - 7539
ASO Visual Abstract: Impact of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis—A Systematic Review and Meta-Analysis Mariana MartinsHugo Santos-SousaBernardo Sousa-Pinto ASO Visual Abstract 08 August 2022 Pages: 7540 - 7541
Co-Localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series Asimina S. CourelliAshwyn K. SharmaJason K. Sicklick Peritoneal Surface Malignancy 18 July 2022 Pages: 7542 - 7548
ASO Author Reflections: Co-Localization of Synchronous Gastrointestinal Stromal Tumors (GISTs) and Peritoneal Mesothelioma (PM): A Case Series Asimina S. CourelliAshwyn K. SharmaJason K. Sicklick ASO Author Reflections 05 August 2022 Pages: 7549 - 7550
ASO Visual Abstract: Co-localization of Gastrointestinal Stromal Tumors (GIST) and Peritoneal Mesothelioma: A Case Series Asimina S. CourelliAshwyn K. SharmaJason K. Sicklick ASO Visual Abstract 05 September 2022 Pages: 7551 - 7552
Validation of a Nomogram to Predict Recurrence in Patients with Mucinous Neoplasms of the Appendix with Peritoneal Dissemination After Cytoreductive Surgery and HIPEC L. Martín RománP. LozanoL. González Bayón Peritoneal Surface Malignancy 25 July 2022 Pages: 7553 - 7563
ASO Author Reflections: Predicting Prognosis in Patients with Pseudomyxoma Lorena Martín RománPablo Lozano LomincharLuis González Bayón ASO Author Reflections 27 July 2022 Pages: 7564 - 7565
ASO Visual Abstract: Validation of a Nomogram to Predict Recurrence in Patients with Mucinous Neoplasms of the Appendix with Peritoneal Dissemination after Cytoreductive Surgery and HIPEC L. Martín RománP. LozanoL. González Bayón ASO Visual Abstract 04 August 2022 Pages: 7566 - 7567
Peritoneal Metastases of Colorectal Origin Treated with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy: The Efficiency of Mitomycin C Jean-Baptiste DelhormeGuillaume SauvinetCécile Brigand Peritoneal Surface Malignancy 26 July 2022 Pages: 7568 - 7576
ASO Visual Abstract: Peritoneal Metastases of Colorectal Origin Treated with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy—The Efficiency of Mitomycin C Jean-Baptiste DelhormeGuillaume SauvinetCécile Brigand ASO Visual Abstract 25 July 2022 Pages: 7577 - 7578
Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy Raja R. NarayanJashodeep DattaMichael I. D’Angelica Hepatobiliary Tumors 27 July 2022 Pages: 7579 - 7588
ASO Author Reflections: Ras-p53 Cooperativity Predicts Recurrence Patterns After Resection of Colorectal Liver Metastases with Adjuvant Local and Systemic Chemotherapy Raja R. NarayanJashodeep DattaMichael I. D’Angelica ASO Author Reflections 30 June 2022 Pages: 7589 - 7590
ASO Visual Abstract: Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy Raja R. NarayanJashodeep DattaMichael I. D’Angelica ASO Visual Abstract 26 August 2022 Pages: 7591 - 7591
Does Intraoperative Frozen Section and Revision of Margins Lead to Improved Survival in Patients Undergoing Resection of Perihilar Cholangiocarcinoma? A Systematic Review and Meta-analysis Tori LenetRichard W. D. GilbertKimberly A. Bertens Hepatobiliary Tumors 25 June 2022 Pages: 7592 - 7602
ASO Visual Abstract: Does Intraoperative Frozen Section and Revision of Margins Lead to Improved Survival for Patients Undergoing Resection of Perihilar Cholangiocarcinoma? A Systematic Review and Meta-Analysis Tori LenetRichard W. D. GilbertKimberly A. Bertens ASO Visual Abstract 27 July 2022 Pages: 7603 - 7604
Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium Junya ToyodaKota SaharaTimothy M. Pawlik Hepatobiliary Tumors 29 June 2022 Pages: 7605 - 7614
ASO Author Reflections: Is Systemic Immune-Inflammation Index a Useful Biomarker After Resection of Extrahepatic Cholangiocarcinoma: Results from the U.S. Extrahepatic Biliary Malignancy Consortium Junya ToyodaKota SaharaTimothy M. Pawlik ASO Author Reflections 01 July 2022 Pages: 7615 - 7616
ASO Visual Abstract: Prognostic Utility of Systemic Immune-Inflammation Index After Resection of Extrahepatic Cholangiocarcinoma—Results from the US Extrahepatic Biliary Malignancy Consortium Junya ToyodaKota SaharaTimothy M. Pawlik ASO Visual Abstract 28 July 2022 Pages: 7617 - 7618
Comprehensive Clinical Analysis of Gallbladder Neuroendocrine Neoplasms: A Large-Volume Multicenter Study During One Decade Yangyang WangBingfeng HuangTingbo Liang Hepatobiliary Tumors 18 July 2022 Pages: 7619 - 7630
ASO Author Reflections: Comprehensive Clinical Analysis of Gallbladder Neuroendocrine Neoplasms Qi ZhangYangyang WangTingbo Liang ASO Author Reflections 06 July 2022 Pages: 7631 - 7631
ASO Visual Abstract: Comprehensive Clinical Analysis of Gallbladder Neuroendocrine Neoplasms—A Large-Volume Multicenter Study over One Decade Yangyang WangQi ZhangTingbo Liang ASO Visual Abstract 27 July 2022 Pages: 7632 - 7633
Dynamic Prediction of Survival After Curative Resection of Intrahepatic Cholangiocarcinoma: A Landmarking-Based Analysis Gaya SpolveratoGiulia CapelliTimothy M. Pawlik Hepatobiliary Tumors 24 July 2022 Pages: 7634 - 7641
ASO Author Reflections: Dynamic Prediction of Survival After Curative Resection of Intrahepatic Cholangiocarcinoma: A Landmarking-Based Analysis Gaya SpolveratoGiulia LorenzoniTimothy M. Pawlik ASO Author Reflections 13 July 2022 Pages: 7642 - 7643
ASO Visual Abstract: Dynamic Prediction of Survival After Curative Resection of Intrahepatic Cholangiocarcinoma: A Landmarking-Based Analysis Gaya SpolveratoGiulia CapelliTimothy M. Pawlik ASO Visual Abstract 29 July 2022 Pages: 7644 - 7645
Total Laparoscopic Resection of an Extrahepatic Mucinous Biliary Cystadenoma with Liver Involvement (with Video) Huanwei ChenFa LuoWan Yee Lau Hepatobiliary Tumors 14 September 2022 Pages: 7646 - 7651
Factors Mediating Racial/Ethnic Disparities in Delayed Treatment of Breast Cancer Margaret C. SchermerhornMiles W. GrunvaldAdan Z. Becerra Breast Oncology 24 June 2022 Pages: 7652 - 7658
ASO Author Reflections: Applying the Counterfactual Approach to Disparities in Breast Cancer Treatment Delays Margaret C. SchermerhornMiles W. GrunvaldAdan Z. Becerra ASO Author Reflections 04 July 2022 Pages: 7659 - 7660
ASO Visual Abstract: Mediating Factors of Racial/Ethnic Disparities in Delayed Treatment of Breast Cancer Margaret C. SchermerhornMiles W. GrunvaldAdan Z. Becerra ASO Visual Abstract 29 August 2022 Pages: 7661 - 7661
Prevalence of Pathologic N2/N3 Disease in Postmenopausal Women with Clinical N0 ER+/HER2− Breast Cancer Maire J. AmlickeJihye ParkPhilip M. Spanheimer Breast Oncology 25 June 2022 Pages: 7662 - 7669
ASO Author Reflections: Can Genomic Recurrence Score Replace SLNB in Postmenopausal Women with ER+/HER2− Breast Cancer? Maire J. AmlickePhilip M. Spanheimer ASO Author Reflections 13 July 2022 Pages: 7670 - 7671
ASO Visual Abstract: Prevalence of Pathologic N2/N3 Disease in Postmenopausal Women with Clinical N0 ER+/HER2– Breast Cancer Maire J. AmlickeJihye ParkPhilip M. Spanheimer ASO Visual Abstract 16 July 2022 Pages: 7672 - 7673
Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer with One to Three Positive Sentinel Lymph Nodes Olga KantorAnna WeissTari A. King Breast Oncology 28 June 2022 Pages: 7674 - 7682
ASO Visual Abstract: Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer with 1-3 Positive Sentinel Lymph Nodes Olga KantorAnna WeissTari A. King ASO Visual Abstract 09 July 2022 Pages: 7683 - 7684
A Noninvasive Tool Based on Magnetic Resonance Imaging Radiomics for the Preoperative Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Chenchen LiNian LuHerui Yao Breast Oncology Open access 30 June 2022 Pages: 7685 - 7693
ASO Visual Abstract: A Noninvasive Tool Based on Magnetic Resonance Imaging Radiomics for the Preoperative Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Chenchen LiNian LuHerui Yao ASO Visual Abstract 04 August 2022 Pages: 7694 - 7695
Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS Faina NakhlisFisher D. KatlinTari A. King Breast Oncology 30 June 2022 Pages: 7696 - 7702
ASO Visual Abstract: The Presence of Non-classic LCIS is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS Faina NakhlisFisher D. KatlinTari A. King ASO Visual Abstract 21 July 2022 Pages: 7703 - 7704
Overuse of Axillary Surgery in Patients with Ductal Carcinoma In Situ: Opportunity for De-escalation Mara A. PiltinTanya L. HoskinJudy C. Boughey Breast Oncology 05 July 2022 Pages: 7705 - 7712
ASO Author Reflections: In an Era of De-escalation, Are We Still Doing Too Much for Stage 0 Breast Cancer? Mara A. PiltinJudy C. Boughey ASO Author Reflections 06 July 2022 Pages: 7713 - 7714